Oriola Oyj

HEL-ORIOLA
Nasdaq Helsinki
Drugs, Drug Proprietaries, and Druggists' Sundries
Global Rank
#19267
Country Rank
#74
Market Cap
224.85 M
Price
1.23
Change (%)
1.66%
Volume
62,243

Oriola Oyj's latest marketcap:

224.85 M

As of 06/18/2025, Oriola Oyj's market capitalization has reached $224.85 M. According to our data, Oriola Oyj is the 19267th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 224.85 M
Revenue (ttm) 2.02 B
Net Income (ttm) -26,674,200
Shares Out 181.41 M
EPS (ttm) -0.15
Forward PE 17.28
Ex-Dividend Date 04/03/2025
Earnings Date 07/18/2025
Market Cap Chart
Data Updated: 06/18/2025

Oriola Oyj's yearly market capitalization.

Oriola Oyj has seen its market value drop from €523.92 M to €224.85 M since 2014, representing a total decrease of 57.08% and an annual compound decline rate (CAGR) of 7.76%.
Date Market Cap Change (%) Global Rank
06/18/2025 €224.85 M 20.8% 19267
12/30/2024 €161.88 M -18.68% 20084
12/29/2023 €199.08 M -38.03% 18245
12/30/2022 €321.23 M -11.39% 14684
12/30/2021 €362.53 M 3.7% 14580
12/30/2020 €349.58 M -4.76% 12459
12/30/2019 €367.06 M 2.36% 11030
12/28/2018 €358.58 M -30.85% 10101
12/29/2017 €518.57 M -33.38% 9347
12/30/2016 €778.46 M -0.06% 7369

Company Profile

About Oriola Oyj

Oriola Oyj is a leading wholesale distributor of pharmaceuticals and health products, operating primarily in Sweden, Finland, and internationally.

Product Offerings

  • Pharmaceuticals and health products
  • Vitamins, food supplements, and sports nutrients
  • Wound care, beauty, and makeup products
  • Vaccines and over-the-counter (OTC) products

Services

  • Pharmaceutical logistics
  • Special licensed medicine importing and dose dispensing
  • Research pharmacy services
  • Commercial data, clinical trial support, and regulatory affairs
  • Medical and scientific affairs, market access, and tenders
  • Real-world evidence, sales support, and medical translation
  • Pharmacovigilance, medical information, and patient support
  • Advisory services

Customer Base

Oriola Oyj serves a diverse range of clients, including:

  • Pharmaceutical companies
  • Pharmacies and veterinarians
  • Hospitals and healthcare providers
  • Specialty stores, retailers, and e-commerce companies

Founded: 1907
Headquarters: Espoo, Finland

Frequently Asked Questions

  • What is Oriola Oyj's (HEL-ORIOLA) current market cap?
    As of 06/18/2025, Oriola Oyj (including the parent company, if applicable) has an estimated market capitalization of $224.85 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Oriola Oyj global market capitalization ranking is approximately 19267 as of 06/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.